The Baird Institute has partnered with the University of Sydney and Royal Prince Alfred Hospital to establish an exciting new Centre for Heart Failure and Diseases of the Aorta. This new venture aims to make advances in the discovery, diagnosis, and treatment of heart failure and aortic diseases. The Centre’s overarching aim is to accelerate novel discovery to improve outcomes for patients with heart failure and aortic disease.
Led by Professor Paul Bannon, Professor John O’Sullivan, and Dr Sean Lal, the centre will apply its unique resources and expertise to address major unmet needs in these fields. The new Centre has a world-leading bench-to-bedside program that has several unique resources on a global scale: Heart Failure Biopsy Programs not available anywhere else; the World’s Largest Heart Biobank; one of the world’s only Aorta Biobanks; and pre-clinical models of Heart Failure and Aortic Disease.
The Centre has a strong governance structure carefully facilitating the linkage between basic science, clinical translation, consumer outreach, and commercialisation. The Centre has established and leads two active clinical trials in heart failure. It will be in a position to capitalise on opportunities in the emerging biomedical precinct incorporating the Sydney Biomedical Accelerator and Tech Central. These strengths coalesce at a critical juncture and will drive important advances in Heart Failure and Aortic disease and improve patient outcomes.
